Saturday
2:00 pm - 5:00 pm
Arrival and Check-in
3:30 pm - 3:45 pm
Introductory Comments by GRC Site Staff / Welcome from the GRS Chair
3:45 pm - 4:30 pm
Keynote Session: How to Maintain a Work/Life Balance as an Early Career Researcher
Discussion Leader: Jenny Parvani (Case Western Reserve University, USA)
3:45 pm - 4:15 pm
Pepper Schedin (Oregon Health and Science University, USA)
"One Scientist's Journey; Finding the Link Between Personal Happiness and Scientific Creativity"
4:15 pm - 4:30 pm
Discussion
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Estrogen and Progesterone Receptor Signaling in Hormone Dependent Cancers
Discussion Leaders: Eric Bolf (University of Vermont, USA) and Matthew Sikora (University of Colorado Anschutz Medical Campus, USA)
7:30 pm - 7:50 pm
Nuria Padilla Just (University of Colorado Anschutz Medical Campus, USA)
"Molecular Determinants of ER+ Breast Cancer Organ-Specific Metastasis"
7:50 pm - 8:00 pm
Discussion
8:00 pm - 8:20 pm
Sankari Nagarajan (Cancer Research UK Cambridge Institute, United Kingdom)
"Genome-Wide CRISPR Screening to Understand Drug Resistance in ER+ Breast Cancer"
8:20 pm - 8:30 pm
Discussion
8:30 pm - 8:45 pm
Hari Singhal (Dana-Farber Cancer Institute, USA)
"Genomic Analyses of Normal and Breast Cancer Tissue Identifies Grainy Head Like 2 (GRHL2) as a Key Tumor-Specific Oncogene"
8:45 pm - 8:50 pm
Discussion
8:50 pm - 9:05 pm
Soleilmane Omarjee (Cancer Research UK Cambridge Institute, United Kingdom)
"Role of ERa-36 in Estrogen Non-Genomic Signaling and Breast Cancer"
9:05 pm - 9:10 pm
Discussion
9:10 pm - 9:25 pm
Lynsey Fettig (University of Colorado Anschutz Medical Campus, USA)
"Progesterone Receptor-Retinoic Acid Receptor Crosstalk in Regulating a Breast Cancer Stem Cell Population"
9:25 pm - 9:30 pm
Discussion
Sunday
7:30 am - 8:30 am
Breakfast
9:00 am - 11:00 am
Androgen Receptor and Other Signaling Mechanisms in Hormone Dependent Cancers
Discussion Leaders: Lucas Brand (Thomas Jefferson University, USA) and Kristine Sikora (University of Colorado Denver, USA)
9:00 am - 9:20 am
Claire Nash (Research Institute of the McGill University Health Centre, Canada)
"Genome-Wide Analysis of AR Binding and Transcriptomic Analysis of Primary Prostate Tumour Stroma and Prostate Mesenchyme"
9:20 am - 9:30 am
Discussion
9:30 am - 9:45 am
Iza Denis (Dame Roma Mitchell Cancer Research Laboratories, Australia)
"AR Chromatin Binding Events Get Reprogrammed in the Absence of FOXA1 in ER-Breast Cancers"
9:45 am - 9:50 am
Discussion
9:50 am - 10:05 am
Chenchu Lin (University of Houston, USA)
"CREB Is a Critical Factor in Androgen Receptor-Mediated Prostate Cancer Proliferation"
10:05 am - 10:10 am
Discussion
10:10 am - 10:30 am
Noelle Gillis (University of Vermont, USA)
"Thyroid Hormone Receptor Beta (TR) Mediates Brama Related Gene 1 (BRG1, SMARCA4) Dependent Chromatin Remodeling for Tumor Suppression in Thyroid Cancer"
10:30 am - 10:40 am
Discussion
10:40 am - 10:55 am
Sakshi Gera (Indian Institute of Science, India)
"Unraveling the Role of Follicle Stimulating Hormone and Notch Signaling in Ovarian Cancer"
10:55 am - 11:00 am
Discussion
11:00 am - 12:30 pm
Poster Session
Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pm - 1:30 pm
Lunch
1:30 pm - 2:30 pm
Mentorship Component: Career Panel
During this session, participants will be able to interact with a number of PhD-level career panelists. These panelists come from a variety of backgrounds, including academia, administration, industry, and scientific writing. Participants will be able to ask questions freely and engage in open discussions. Each panelist will offer a unique perspective and valuable advice for success for all of the early career scientists in attendance.
Discussion Leader: Aarti Rohira (Baylor College of Medicine, USA)
1:30 pm - 2:30 pm
Panel Discussion
Career Development Advice for Different Career Paths
Kristine Sikora (University of Colorado Denver, USA)
Matthew Sikora (University of Colorado Anschutz Medical Campus, USA)
Luis Solorio (Purdue University, USA)
Christopher Morrow (AstraZeneca, United Kingdom)
2:30 pm - 3:00 pm
Evaluation Period
Fill in GRS Evaluation Forms
3:00 pm
Seminar Concludes